Menu Search
Equities

MERCK DRN

MRCK34:SAO

MERCK DRN

Actions
  • Price (BRL)72.13
  • Today's Change-0.43 / -0.59%
  • Shares traded14.58k
  • 1 Year change+15.65%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 21:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		MRK:NYQ since
announced		Transaction
value
Modifi Biosciences IncDeal completed23 Oct 202423 Oct 2024Deal completed-7.00%1.33bn
Unity Semiconductor SasAnnounced18 Jul 202418 Jul 2024Announced-21.22%--
Eyebiotech LtdDeal completed29 May 202429 May 2024Deal completed-21.34%3.00bn
Abceutics IncDeal completed05 Apr 202405 Apr 2024Deal completed-22.31%208.00m
Data delayed at least 15 minutes, as of Nov 22 2024 21:10 GMT.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Caixa DTVM SAas of 30 Jun 2024288.97k0.00%
Banco J. Safra SAas of 30 Jun 2024136.00k0.00%
BRAM - Bradesco Asset Management SA DTVMas of 30 Jun 202442.53k0.00%
Safra Asset Management Ltda.as of 30 Jun 202441.60k0.00%
XP Allocation Asset Management Ltda.as of 30 Jun 20242.76k0.00%
More ▼
Data from 30 Jun 2024 - 08 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.